Výsledky vyhledávání - "R S, Medansky"

Mometasone furoate cream 0.1% vs. hydrocortisone cream 1% in the treatment of seborrhoeic dermatitis

Autor: C. R. Samson, E. A. Peets, M. I. Lepaw, R. S. Medansky, E. H. Zimmerman, M. L. Jones, E. Taylor, J. S. Shavin

Publikováno v: Journal of Dermatological Treatment. 3:125-128

The safety and efficacy of mometasone furoate cream 0.1% (applied once daily), and hydrocortisone cream 1% (applied twice. daily) were compared in a 6-week multicentre, randomized, third-party-blin...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e41d5d6fa4493b7a9153b32838f84e24
https://doi.org/10.3109/09546639209088705

Zobrazit plný text záznamu

Intermittent Corticosteroid Maintenance Treatment of Psoriasis: A Double-Blind Multicenter Trial of Augmented Betamethasone Dipropionate Ointment in a Pulse Dose Treatment Regimen

Autor: C. R. Samson, M. L. Jones, R S Medansky, John J. Mooney, H I Katz, S E Prawer, Gerald G. Krueger

Publikováno v: Dermatology. 183:269-274

Ninety psoriasis patients, who were either completely cleared of or manifested only a minimal presence of disease signs following 3–4 weeks of twice daily treatment with augmented betamethasone dipropionate (ABD) ointment 0.05%, were enrolled in th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dab3a35fe89cd72d456fcd29282c31b
https://doi.org/10.1159/000247698

Zobrazit plný text záznamu

SCH 370 (clotrimazole-betamethasone dipropionate) cream in patients with tinea cruris or tinea corporis

Autor: H I, Katz, J, Bard, G W, Cole, S, Fischer, G E, McCormick, R S, Medansky, L T, Nesbitt, I H, Rex

Publikováno v: Cutis. 34(2)

The safety and efficacy of SCH 370 (1 percent clotrimazole/0.05 percent betamethasone dipropionate) cream was compared with each of its individual components in 331 patients with tinea cruris or tinea corporis. The study was a multicentered, randomiz

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::737200de42b876f3c0da994c49dc1e6e
https://pubmed.ncbi.nlm.nih.gov/6383734

Zobrazit plný text záznamu

Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent

Autor: R S, Medansky, R, Bressinck, G W, Cole, J H, Deeken, C N, Ellis, J D, Guin, J H, Herndon, A E, Lasser, E, Leibsohn, M A, Menter

Publikováno v: Cutis. 42(5)

Mometasone furoate (Elocon) is a newly formulated and unique medium-potency synthetic 17-heterocyclic corticosteroid. The efficacy and safety of the ointment and cream formulations (0.1 percent) of the corticosteroid, administered once daily, were co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6c57536a2be7eb11e103ef18bf570f52
https://pubmed.ncbi.nlm.nih.gov/3058398

Zobrazit plný text záznamu

Analysis of a new corticosteroid aerosol in treatment of contact dermatitis

Autor: R S, Medansky, R M, Handler

Publikováno v: Cutis. 21(1)

In multicentric clinical trial involving twelve investigators and 271 patients, betamethasone dipropionate (0.1 percent) aerosol was found to be significantly more effective than its vehicle in the treatment of moderate to severe contact dermatitis.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6d084e1769d819b63e114351352f0627
https://pubmed.ncbi.nlm.nih.gov/624224

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání